A Prospective Protocol of Stereotactic Body Irradiation with Concurrent Intraprostatic Lesion Boost Utilizing Intensity Modulated Radiotherapy for Patients with Low- and Intermediate-Risk Prostate Cancer, NCT01409473
PURPOSE OF THIS CLINICAL RESEARCH TRIAL
The purpose of this study is to determine whether stereotactic body radiation therapy (SBRT) with simultaneous boost (higher radiation dose) to areas within the prostate with more prominent cancerous growth (intraprostatic lesions) utilizing intensity modulated radiotherapy (IMRT) planning techniques is a safe and effective treatment in patients with low- and intermediate-risk localized prostate cancer.
MORE DETAILS ON THIS TRIAL
SBRT 511-03 (i1593) / NCT01409473 / Open 8-11-2011